Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Paul Kusserow Insider Profile
4 Followers
Paul Kusserow, Director at Amedisys, holds 353.67K shares in Amedisys (Ticker: AMED), holds 0.00 shares in Oak Street Health (Ticker: OSH), holds 0.00 shares in Connecture Inc (Ticker: CNXR).
Paul Kusserow has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
The most profitable trade made by Paul Kusserow
Paul Kusserow's Trading History
Amedisys
May 07, 2024
Director
Uninformative Buy
―
$34.52M
Oak Street Health
May 02, 2023
―
Uninformative Sell
18.72M
$0.00
Connecture Inc
Apr 27, 2018
―
Uninformative Sell
42.66K
$0.00
Humana
Jun 25, 2013
Former Sr VP
Uninformative Sell
2.89M
$14.99M
List of latest transactions for each holding click on a transaction to see Paul Kusserow's performance on stock
You May Also Like
Paul Kusserow insider profile FAQ
What is the percentage of profitable transactions made by Paul Kusserow?
The percentage of profitable transactions made by Paul Kusserow is ―.
What is the average return per transaction made by Paul Kusserow?
The average return per transaction made by Paul Kusserow is ―.
What stocks does Paul Kusserow hold?
Paul Kusserow holds: AMED, OSH, CNXR, HUM stocks.
What was Paul Kusserow’s latest transaction?
Paul Kusserow latest transaction was an Uninformative Buy of ―.
What was Paul Kusserow's most profitable transaction?
Paul Kusserow’s most profitable transaction was an Informative Sell of HUM stock on February 28, 2012. The return on the trade was 21.80%.
What is Paul Kusserow's role in Amedisys?
Paul Kusserow's role in Amedisys is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.